Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes

被引：10
|
作者：
Marcinkiewicz, Janusz [1 ]
Mazurek, Henryk [2 ]
Majka, Grzegorz [1 ]
Chain, Benjamin [3 ]
机构：
[1] Jagiellonian Univ Med Coll, Fac Med, Chair Immunol, Ul Czysta 18, PL-31121 Krakow, Poland
[2] Inst TB & Lung Disorders, Dept Pneumonol & Cyst Fibrosis, Rabka Zdroj, Poland
[3] UCL, Div Infect & Immun, London, England
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2020年 / 130卷 / 10期
关键词：
PEOPLE;
D O I：
10.20452/pamw.15630
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：919 / 920
页数：2
相关论文
共 50 条
  • [21] Severe COVID-19 outcomes in patients with psoriasis
    Lima, X. T.
    Cueva, M. A.
    Lopes, E. M.
    Alora, M. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : E776 - E778
  • [22] Cardiac Fibrosis Is a Risk Factor for Severe COVID-19
    Mustroph, Julian
    Hupf, Julian
    Baier, Maria J.
    Evert, Katja
    Brochhausen, Christoph
    Broeker, Katharina
    Meindl, Christine
    Seither, Benedikt
    Jungbauer, Carsten
    Evert, Matthias
    Maier, Lars S.
    Wagner, Stefan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] COVID-19: Rare variants increase the risk of severe COVID-19
    van de Veerdonk, Frank L.
    Netea, Mihai G.
    ELIFE, 2021, 10
  • [24] Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes
    Khan, Shahzad
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (03): : 178 - 191
  • [25] Asthma as a predictor of more severe outcomes in COVID-19 infection
    Eggert, Lauren
    Cao, Shu
    He, Ziyuan
    Dhondalay, Gopal Krishna
    Jiang, Shirley
    Collins, William
    Sindher, Sayantani
    Nadeau, Kari
    Sharon Chinthrajah, R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB44 - AB44
  • [26] Patients with low ALT levels are at increased risk for severe COVID-19
    Genzel, Dor
    Katz, Lior H.
    Safadi, Rifaat
    Rozenberg, Aliza
    Milgrom, Yael
    Jacobs, Jeremy M.
    Shafrir, Asher
    FRONTIERS IN MEDICINE, 2023, 10
  • [27] PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
    Jackson, Ian
    Jaradeh, Hadi
    Aurit, Sarah
    Aldamen, Ali
    Narechania, Shraddha
    Destache, Chris
    Velagapudi, Manasa
    CHEST, 2021, 160 (04) : 541A - 541A
  • [28] Lung ultrasound as a predictor of mortality of patients with COVID-19
    Sosa, Fernando A.
    Matarrese, Agustin
    Saavedra, Santiago
    Osatnik, Javier
    Roberti, Javier
    Tort Oribe, Barbara
    Ivulich, Daniel
    Laura Duran, Ana
    Caputo, Celeste
    Benay, Cristian
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (04)
  • [29] Fever as a Predictor of COVID-19 Outcomes in Hospitalized Patients
    Silva, Lucas Pereto
    Stocco, Rebecca Benicio
    Pereira, Marcos Roberto Curcio
    Koga, Julia Naomi
    Gomes, Isabela Pontarolo
    Carvalho, Joao Eduardo
    Beni, Giovana Muniz
    Negreiros, Paulo
    Baena, Cristina P.
    Marques, Gustavo Lenci
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [30] Diabetes severity and the risks of COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Floyd, James
    Walker, Rod
    Kuntz, Jennifer
    Shortreed, Susan
    Fortmann, Stephen
    Bayliss, Elizabeth
    Harrington, Laura
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Powers, John
    Lee, Mi
    Temposky, Lisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 40
12345